Take action based on the earliest and most subtle physiological indicators and provide your patients with the care they deserve.
Provide your patient with remote feedback based on analyzed aggregated data presented in a user-friendly, secure interface.
Having access to high-resolution V-LAP readings will allow you to diagnose additional cardiac conditions like mitral regurgitation, arrhythmias, diastolic dysfunction and more, using sensitive automated supportive algorithms.
Make better decisions based on artificial intelligence that uses pattern recognition algorithms, to design the best recovery plan.
The system maps out heart failure decompensation based on mean left atrial pressure readings, so that physicians can detect impending exacerbations and act accordingly. Furthermore, physicians can drill down to daily high-resolution left atrial pressure waveform morphology, receiving input regarding common co-morbidities.
The increase of left atrial pressure is the most specific and earliest sign of impending heart failure exacerbation – long before clinical symptoms occur. V-LAP’s unmet clinical need has been evident for years, and the cardiology profession will benefit greatly from the availability of technology that can provide this valuable indication non-invasively on a daily basis.
Ohio State University Medical Center Division of Cardiovascular Medicine, USA
This technology will really change the way we manage patients with severe heart failure. V-LAP is the first device that specifically enables us to monitor pressure within the left side of the heart - and because of its cloud-based system, we can access patient data on-demand, monitoring the atrial pressure and managing dosages, medications and overall quality of life consistently and remotely.
Director of the CardioVascular Center Frankfurt, Germany
Vectorious’ V-LAP holds the potential of great promise for clinical use in Class III heart failure patients; with potential to improve quality of life, reduce mortality, and reduce rates of hospital admissions in this population. V-LAP is uniquely designed, and will be the first fully miniaturized, battery-free and leadless active device to measure left atrial pressure in the market.
Professor of Cardiovascular Medicine and Director of Structural Interventional Cardiology at Careggi University Hospital, Florence, Italy
Want to learn more about Vectorious? Contact us today and let’s have a heart to heart conversation.